Drug Type Recombinant LBP |
Synonyms- |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Novome Biotechnologies, Inc.Startup |
Active Organization- |
Inactive Organization Novome Biotechnologies, Inc.Startup |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperoxaluria | Phase 2 | US | Novome Biotechnologies, Inc.Startup | 02 Jun 2021 |